Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
118 participants
INTERVENTIONAL
2013-02-28
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to investigate the efficacy of NFT as compared to a sham-feedback condition and a cognitive behavioral treatment in adults with persistent ADHD.
Efficacy is assessed on several outcome parameters, such as symptom severity, neuropsychological variables (e.g., attention, memory), and EEG parameters.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback Study ADHD
NCT01879644
An Evaluation of Neurofeedback Efficacy in Adults With ADHD
NCT01852357
Neurofeedback and Working Memory Training for Children and Adolescents With ADHD
NCT01841151
Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD
NCT02358941
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurofeedback active
Active neurofeedback training, theta/beta-protocol
Neurofeedback active
Neurofeedback sham
Neurofeedback training is simulated to subjects in this condition
Neurofeedback active
Neurofeedback sham
Metacognitive Training
Metacognitive training, cognitive behavioral therapy
Metacognitive Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback active
Neurofeedback sham
Metacognitive Training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sufficient knowledge of the German language
Exclusion Criteria
* neurological disorder (e.g., epilepsy)
* current substance abuse disorder
* receives psychotherapy (e.g., CBT) or medication
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Research Foundation
OTHER
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Michael Schoenenberg
Efficacy of a Neurofeedback Treatment in Adults With ADHD: a Triple-blind Randomized Placebo-controlled Study
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Schönenberg, Dr
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen
Martin Hautzinger, Prof. Dr.
Role: STUDY_CHAIR
University Hospital Tuebingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universität Tübingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schonenberg M, Wiedemann E, Schneidt A, Scheeff J, Logemann A, Keune PM, Hautzinger M. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial. Lancet Psychiatry. 2017 Sep;4(9):673-684. doi: 10.1016/S2215-0366(17)30291-2. Epub 2017 Aug 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCHO 1448/2-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.